Healthtech Startups
16,920 companies tagged Healthtech, with their investors and founders.
Healthfuse is a Milwaukee-based company that works with hospital partners, including national hospital systems. The page focuses on the team and community giving rather than detailing the product.
2 investors
HealthHub is a digital healthcare SaaS platform providing medical information tools for both healthcare providers and patients. It focuses on patient-centered smart healthcare experiences.
2 investors
HealthKey provides AI-powered patient identification for clinical trial teams by integrating with electronic health records to automatically prescreen and identify eligible trial candidates. The platform uses machine learning to analyze patient data and match participants against trial eligibility criteria, serving clinical research organizations and trial sites.
2 investors
2 investors
HealthPlix provides an online and offline electronic medical record (EMR) platform and clinic management software for doctors and healthcare facilities in India, including prescription tools, teleconsultation, and specialty-specific modules across 16 medical specialties. The company serves over 14,000 doctors and supports patient care in 370+ cities with prescriptions available in 14 languages.
2 investors
A healthcare-focused investment firm managing approximately $2 billion in assets across 52 portfolio companies. The firm invests in commercial-stage healthcare companies including services, IT, medical devices, diagnostics, and pharma services.
2 investors
Healthtech1 offers Bookable, a patient booking and care-navigation tool that helps GP practices in the UK surface appointment availability, register and navigate patients, and grow their patient list with reduced administrative work. It automates patient registrations and appointment booking while adding guardrails to preserve continuity of care.
2 investors
2 investors
Healx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
2 investors
HeartGenetics develops personalized genetic tests and reports for cardiovascular health, pharmacogenetics, and wellness using a DNA microchip platform and computational algorithms. The company serves healthcare providers and patients seeking genetic insights for preventive and personalized medicine.
2 investors
hearX develops mobile applications for hearing screening and monitoring using validated audio testing technology. The company serves the general public and healthcare providers with affordable, clinically-backed hearing assessment tools.
2 investors
Hoow Foods develops healthier and more sustainable foods by combining expertise in healthcare, food science, and technology. The company targets consumers seeking nutritionally improved food products.
2 investors
Heim provides a platform that enables in-person clinical care delivery to patients' homes, integrating with existing healthcare provider systems. The service targets patients and healthcare practitioners seeking to expand access to clinical care beyond traditional office settings.
2 investors
Helicore Bio develops long-acting antibody-peptide conjugate therapies for obesity and cardiometabolic disease, using proprietary GLP-1R agonist and amylin receptor agonist peptide libraries combined with a GIP ligand-binding antibody backbone. Its pipeline targets quarterly-dosed treatments, with a first-in-class GIP-binding antibody validated in a Phase 1 study.
2 investors
Hello Inside sells continuous glucose monitoring (CGM) sensors for 14-day glucose tracking. The company operates with country-specific sensor models due to regulatory requirements.
2 investors
hellocare.ai is an end-to-end virtual care delivery platform combining software, hardware, and AI to support virtual nursing, virtual sitting, telehealth, and remote patient monitoring. It provides turnkey solutions for hospitals, home care, and primary care providers, enabling clinicians to remotely monitor and interact with patients.
2 investors
Grouper connects people through shared group activities and clubs to promote healthy aging and social engagement. The platform serves older adults and communities looking to participate in recreational and social groups that support wellness and active lifestyles.
2 investors
Pando is a secure messaging and clinical collaboration platform that lets clinicians communicate with each other and connects patients to specialists. It serves healthcare organisations and professionals, with usage across NHS hospitals, clinics and communities in the UK.
2 investors
HelpNow operates a network of ambulances and converted medical transport vehicles to provide rapid emergency response services in India.
2 investors
Hemex Health develops and commercializes the Gazelle diagnostic platform, including point-of-care readers and tests for conditions such as sickle cell disease and hemoglobin variants. It targets clinicians, patients, and public health programs in emerging and resource-limited markets, with significant operations and manufacturing in India.
2 investors
HepaTx develops stem cell-based hepatocyte therapies for liver disease treatment as an alternative to organ transplantation. The company targets niche liver disease indications including alpha-1 antitrypsin deficiency, phenylketonuria, and non-alcoholic steatohepatitis.
2 investors
Hello Hera provides senior care coordination services delivered by human "Heroes" supported by AI, handling insurance, appointments, medication management, and other non-clinical care tasks for families with aging parents. The service is covered by Medicare, targeting families managing complex senior healthcare needs.
2 investors
A fertility diagnostics company offering semen analysis testing services across multiple locations in North America.
2 investors
HeraSight develops genetic tests for families, including preimplantation embryo screening that uses polygenic risk scores and carrier screening to predict risks for conditions such as Alzheimer's, schizophrenia, cancers, autism, and diabetes. It combines validated polygenic scoring with genetic counseling for prospective parents undergoing IVF.
2 investors